Jack Lin
Stock Analyst at Morgan Stanley
(1.10)
# 3,838
Out of 5,005 analysts
29
Total ratings
47.6%
Success rate
-2.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2256 Abbisko Cayman Limited | Reiterated: Buy | $22.00 | $8.75 | +151.43% | 2 | Sep 4, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $215.00 → $212.00 | $92.00 | +130.43% | 4 | Aug 26, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $123.00 → $138.50 | $96.15 | +44.05% | 2 | Aug 25, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $17.00 | $14.10 | +20.57% | 4 | Aug 25, 2026 | |
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $14.13 | -3.75% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Reiterated: Hold | $21.45 → $21.30 | $22.20 | -4.05% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $493.00 | $194.60 | +153.34% | 2 | Nov 20, 2025 | |
| HKG: 9688 Zai Lab Limited | Reiterated: Buy | $37.50 → $37.44 | $19.92 | +87.95% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $89.00 | $71.20 | +25.00% | 2 | Oct 30, 2025 | |
| HKG: 1952 Everest Medicines Limited | Reiterated: Hold | $55.00 | $28.36 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93.50 | $73.15 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $25.69 | n/a | 3 | Sep 21, 2025 |
Abbisko Cayman Limited
Sep 4, 2026
Reiterated: Buy
Price Target: $22.00
Current: $8.75
Upside: +151.43%
Akeso, Inc.
Aug 26, 2026
Reiterated: Buy
Price Target: $215.00 → $212.00
Current: $92.00
Upside: +130.43%
Innovent Biologics, Inc.
Aug 25, 2026
Reiterated: Buy
Price Target: $123.00 → $138.50
Current: $96.15
Upside: +44.05%
InnoCare Pharma Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $17.00
Current: $14.10
Upside: +20.57%
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $14.13
Upside: -3.75%
HUTCHMED (China) Limited
May 28, 2026
Reiterated: Hold
Price Target: $21.45 → $21.30
Current: $22.20
Upside: -4.05%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Reiterated: Buy
Price Target: $493.00
Current: $194.60
Upside: +153.34%
Zai Lab Limited
Nov 6, 2025
Reiterated: Buy
Price Target: $37.50 → $37.44
Current: $19.92
Upside: +87.95%
RemeGen Co., Ltd.
Oct 30, 2025
Reiterated: Hold
Price Target: $89.00
Current: $71.20
Upside: +25.00%
Everest Medicines Limited
Sep 22, 2025
Reiterated: Hold
Price Target: $55.00
Current: $28.36
Upside: n/a
Sep 22, 2025
Reiterated: Buy
Price Target: $93.50
Current: $73.15
Upside: n/a
Sep 21, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $25.69
Upside: n/a